You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vascepa

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Adenoma, Colorectal Cancer, Endoscopic Surgery Trial in Boston (AMR101)

Completed
  • Colorectal Adenoma
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 18, 2022

Hypertriglyceridemia Trial in Torrance, Murray (Vascepa, )

Completed
Has Results
  • Hypertriglyceridemia
  • Vascepa
  • placebo
  • Torrance, California
  • +1 more
Oct 4, 2021

Lipid Disorder, Triglycerides High, Dyslipidemias Trial in Philadelphia (Icosapent Ethyl 1000 MG [Vascepa])

Completed
Has Results
  • Lipid Disorder
  • +2 more
  • Icosapent Ethyl 1000 MG [Vascepa]
  • Philadelphia, Pennsylvania
    Perelman School of Medicine at the University of Pennsylvania
Oct 15, 2021

Cardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High Trial in Canada (Icosapent Ethyl 1000 MG Oral Capsule

Recruiting
  • Cardiovascular Diseases
  • +3 more
  • Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
  • North York, Ontario, Canada
  • +3 more
Nov 7, 2022

COVID-19, Inflammatory Response Trial in Toronto (Icosapent ethyl)

Completed
  • COVID-19
  • Inflammatory Response
  • Icosapent ethyl
  • Toronto, Ontario, Canada
    North York Diagnostic and Cardiology Clinic
Dec 21, 2021

Diabetes, Non-Insulin-Dependent, Hypertriglyceridemia Trial in Baton Rouge (Metformin Eicosapentaenoate, Metformin HCl and

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Hypertriglyceridemia
  • Metformin Eicosapentaenoate
  • Metformin HCl and Vascepa
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Apr 25, 2022

Covid19, Atherosclerosis, Cardiovascular Diseases Trial in Oakland (Icosapent ethyl)

Active, not recruiting
  • Covid19
  • +3 more
  • Icosapent ethyl
  • Oakland, California
    Kaiser Permanente Northern California
Jan 7, 2022

Type 2 Diabetes, Coronary Artery Disease Trial in Boston (Icosapent ethyl)

Terminated
Has Results
  • Type 2 Diabetes
  • Coronary Artery Disease
  • Icosapent ethyl
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 22, 2022

Colon Cancer Trial in Boston (AMR101 (VASCEPA, icosapent ethyl))

Withdrawn
  • Colon Cancer
  • AMR101 (VASCEPA, icosapent ethyl)
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 10, 2021

Hypertriglyceridemia Trial in United States (Omega 3 pentaenoic acid, icosapent ethyl)

Completed
Has Results
  • Hypertriglyceridemia
  • Omega 3 pentaenoic acid
  • icosapent ethyl
  • Jacksonville, Florida
  • +7 more
Mar 3, 2022

COVID19 Trial in Rosario (Icosapent ethyl (IPE), Placebo)

Completed
  • COVID19
  • Icosapent ethyl (IPE)
  • Placebo
  • Rosario, Santa Fe, Argentina
    Instituto de Investigaciones Clínicas - Rosario
Sep 10, 2021

Alzheimer's Disease Trial in Madison (icosapent ethyl (IPE), gel cap )

Active, not recruiting
  • Alzheimer's Disease
  • icosapent ethyl (IPE)
  • gel cap placebo
  • Madison, Wisconsin
    William S. Middleton Memorial Veterans Hospital, Madison, WI
Jul 23, 2021

Liver Metastasis, Colon Cancer Trial in United Kingdom (Icosapent Ethyl, Placebo)

Recruiting
  • Liver Metastasis
  • Colon Cancer
  • Icosapent Ethyl
  • Placebo
  • Oxford, Oxfordshire, United Kingdom
  • +12 more
Nov 7, 2022

Nonalcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease (NAFLD) Trial in New Zealand, United States (SEL, FIR,

Completed
Has Results
  • Nonalcoholic Steatohepatitis (NASH)
  • Nonalcoholic Fatty Liver Disease (NAFLD)
  • Chandler, Arizona
  • +12 more
Mar 7, 2022

People of South Asian Descent With Atherosclerotic

Active, not recruiting
  • Cardiovascular Diseases
  • +3 more
    • Ajax, Ontario, Canada
    • +4 more
    Apr 25, 2022

    Coronary Artery Disease (CAD) Trial in Worldwide (Evolocumab, Placebo, Statin therapy)

    Completed
    Has Results
    • Coronary Artery Disease (CAD)
    • Los Angeles, California
    • +32 more
    Apr 7, 2022

    Cardiovascular Diseases Trial in Worldwide (AMR101, Placebo, Statin therapy)

    Completed
    Has Results
    • Cardiovascular Diseases
    • Birmingham, Alabama
    • +409 more
    Mar 21, 2022

    Hypertriglyceridemia Trial in Neptune (rosuvastatin 40 mg tablet, Epanova™ QD (2 x 1 g capsules), Multiple doses of 4 g Epanova™

    Completed
    • Hypertriglyceridemia
    • rosuvastatin 40 mg tablet
    • +3 more
    • Neptune, New Jersey
      Celerion
    Aug 16, 2016

    Infertility, Female, Obesity Trial in Aurora (other, dietary supplement, drug)

    Completed
    • Infertility, Female
    • Obesity
    • Microdialysis
    • +3 more
    • Aurora, Colorado
      University of Colorado Denver Anschutz Medical Campus
    Mar 12, 2015